Gumintad, Maximo B.
HRN: 11-94-20 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/22/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/22/2026
05/28/2026
IV
500mg
Q8H
Amoebiasis
Checking Initial Appropriateness
05/25/2026
METRONIDAZOLE 500MG (TAB)
05/25/2026
05/30/2026
PO
750
Q8
Amoebiasis
Checking Initial Appropriateness